Söndag 22 December | 08:15:40 Europe / Stockholm

Kalender

Tid*
2024-12-20 - Kvartalsrapport 2024-Q3
2024-12-16 - 15-6 2024
2024-08-22 - Kvartalsrapport 2024-Q2
2024-08-14 - Extra Bolagsstämma 2024
2024-05-29 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2024-05-28 - Årsstämma
2024-05-15 - Kvartalsrapport 2024-Q1
2024-02-15 - Bokslutskommuniké 2023
2023-11-09 - Kvartalsrapport 2023-Q3
2023-08-17 - Kvartalsrapport 2023-Q2
2023-05-26 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2023-05-25 - Årsstämma
2023-05-11 - Kvartalsrapport 2023-Q1
2023-02-16 - Bokslutskommuniké 2022
2022-11-17 - Kvartalsrapport 2022-Q3
2022-08-25 - Kvartalsrapport 2022-Q2
2022-06-03 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2022-06-02 - Årsstämma
2022-05-24 - Kvartalsrapport 2022-Q1
2022-03-02 - Bokslutskommuniké 2021
2021-11-25 - Kvartalsrapport 2021-Q3
2021-08-26 - Kvartalsrapport 2021-Q2
2021-06-17 - X-dag ordinarie utdelning CIRCA 0.00 NOK
2021-06-16 - Årsstämma
2021-05-27 - Kvartalsrapport 2021-Q1
2021-03-02 - Bokslutskommuniké 2020

Beskrivning

LandNorge
ListaEuronext Growth Oslo
SektorHälsovård
IndustriBioteknik
Circa Group är verksamma inom bioteknik. Bolaget är en utvecklare av biokemikalier som vidare används för omvandling av avfallsmassa till diverse biokemiskt material. Tekniken används inom energisektorn vid olika produktionsprocesser. Bolaget grundades under 2006 och innehar störst verksamhet runtom den europeiska marknaden. Circa Group har sitt huvudkontor i Oslo, Norge.
2023-06-13 08:00:00
OSLO, NORWAY - 13 JUNE 2023 - Sustainable biochemicals company Circa Group AS
(stock symbol: CIRCA) welcomes Dr Alessandro Napoli as VP Product Development,
commencing September 2023.

Joining the Circa leadership team, Alessandro's responsibilities include
development of levoglucosenone derivatives as well as optimizing process
chemistry for the ReSolute and FC6 manufacturing operations.

Following a PhD in materials science from ETH Zurich and post doc work including
biomaterials, Dr Napoli has held management roles with Huntsman Corporation in
Europe involving both opportunity identification and development including most
recently leading the New Material Platforms Team.

Tony Duncan, CEO of Circa Group AS, said, "Alessandro is an important addition
to Circa's expert resources. As a platform molecule, levoglucosenone can be
developed into a wide range of new, lower carbon high performance chemicals for
different applications, and Alessandro brings a strong commercial focus to
innovation that will greatly benefit Circa's product development timelines."

"I am excited for the opportunity to join Circa and contribute to realising the
potential that sustainable chemicals have to transform the chemical industry.
Further developing the performance and uniqueness of levoglucosenone and its
derivatives will strengthen Circa's innovation pipeline" says Dr Alessandro
Napoli.

About Circa
Established in 2006, Circa Group converts sustainable, non-food biomass into
advanced bio-based chemicals with its proprietary FuracellTM process. By creating
renewable chemicals from cellulose, Circa is extracting value from non-food
biomass and addressing a gap in the market by providing bio-based, less carbon
intensive alternatives, contributing to a more circular economy. In March 2021,
Circa Group successfully listed on the Euronext Growth Market in Oslo, stock
symbol CIRCA.
https://circa-group.com


Investor Contact
Tone Leivestad
Chief Financial Officer
Circa Group AS
tone.leivestad@circa-group.com
Tel: +47 406 39